Recall: Watson Laboratories Hydrocodone Bitartrate And APAP Tablets
On 2017-05-26, the FDA announced that Watson Laboratories is conducting a recall on Hydrocodone Bitartrate And APAP Tablets due to a possible undetermined hazard. The recalled products were sold under the brand name(s) Watson Laboratories during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 1 drugs recalls due to potential undetermined hazard, including duramycin-10 soluble powder, norepinephrine bitartrate added to sodium chloride and more. Additionally, there have been 13 drug and medical device recalls due to other health hazards as well as 130 food recalls.
Company Contact Information:
Name: Watson Laboratories
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Hydrocodone Bitartrate and APAP Tablets
Brand Name(s): Watson Laboratories
Reason for Recall: Undetermined Hazard
Official Recall Date: 2017-05-24
Note: Although this recall announcement is dated 05/24/2017, it was not published by the FDA until 05/26/2017.
Additional information provided by the FDA.gov:
Voluntary recall limited to Lot # JB5047 of BRILINTA (ticagrelor) 90 mg tablets, 8-count Professional (Physician) Sample Bottles Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.